Results 141 to 150 of about 7,903,247 (198)

CD4<sup>+</sup> T-cell responses directed towards A/H5N1-derived haemagglutinin peptides increase in patients with seasonal influenza A virus infection. [PDF]

open access: yesClin Transl Immunology
Allen LF   +14 more
europepmc   +1 more source

Advances in the Development of a Universal Influenza Vaccine. [PDF]

open access: yesAntibodies (Basel)
Mudaly P, Lee M, Bhatta A, Thompson C.
europepmc   +1 more source

Avian influenza in humans

open access: yesJournal of the Royal College of Physicians of Edinburgh, 2005
openaire   +1 more source

Perspective on human diagnostic and national reference laboratory preparedness for zoonotic influenza in Europe. [PDF]

open access: yesEuro Surveill
Felix Garza ZC   +5 more
europepmc   +1 more source

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection. [PDF]

open access: yesVirus Evol
Kikawa C   +23 more
europepmc   +1 more source

Transmission of influenza A in human beings

The Lancet Infectious Diseases, 2007
Planning for the next influenza pandemic is occurring at many levels throughout the world, spurred on by the recent spread of H5N1 avian influenza in Asia, Europe, and Africa. Central to these planning efforts in the health-care sector are strategies to minimise the transmission of influenza to health-care workers and patients.
Gabrielle, Brankston   +4 more
  +7 more sources

A “universal” human influenza A vaccine

Virus Research, 2004
We have previously reported on a universal human influenza A vaccine, based on the external domain of the transmembrane viral M2-protein (M2e) [Nature Medicine 5 (1999) 1119]. M2-protein is scarcely present on the virus but is abundantly expressed on virus-infected cells.
W, Fiers   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy